Contrarily, epicoccin A co-treatment significantly restored the neuronal damage in PD, as evidenced by the notable increase in the fluorescent-labeled length of DA neurons, remarkable upregulation of hoxb1a expression, and significant downregulation of tuba1b [53,54,55]. This evidence concerns the gene TUBA1B and Parkinson disease.